Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition
Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates
Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey
Pamela Roff, B.S. on LinkedIn: What is POTS?
Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…
Pamela Roff, B.S. on LinkedIn: Vagus Nerve Dysfunction in the Post-COVID-19 Condition